Cost-utility analysis of insulin glargine compared with NPH insulin in patients with type 1 diabetes in Spain

被引：0

|

作者：

Terrés, CR

Rodríguez, J

Bolinder, B

De Pablos, P

机构：

来源：

DIABETES | 2004年 / 53卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A291 / A292

页数：2

相关论文

共 50 条

[1] Economic analysis of insulin glargine compared with NPH insulin in the treatment of patients with Type 1 diabetes in Spain
Terrés, CR
Rodríguez, J
Bolinder, B
de Pablos, P
DIABETOLOGIA, 2004, 47 : A345 - A345
[2] Pharmacoeconomic analysis of insulin glargine compared with NPH insulin in patients with type 2 diabetes in Spain
Terres, CR
Rodríguez, J
Bolinder, B
De Pablos, P
DIABETES, 2004, 53 : A291 - A291
[3] Cost analysis of diabetes treatment with glargine insulin or NPH insulin in Spain
Rubio-Terrés, C
Rodriguez, J
Bolinder, B
VALUE IN HEALTH, 2003, 6 (03) : 336 - 336
[4] A cost-utility analysis of insulin glargine (LANTUS®) in the treatment of patients with type 1 diabetes
Kristensen, FK
Sverre, JM
Bustad, S
VALUE IN HEALTH, 2003, 6 (06) : 682 - 682
[5] Cost-utility analysis of insulin pumps compared to multiple daily doses of insulin in patients with type 1 diabetes mellitus in Spain
Conget Donlo, Ignacio
Serrano Contreras, David
Rodriguez Barrios, Jose Manuel
Levy Mizrahi, Isaac
Castell Abat, Conxa
Roze, Stephan
REVISTA ESPANOLA DE SALUD PUBLICA, 2006, 80 (06): : 679 - 695
[6] Economic evaluation of the use of insulin glargine compared with NPH insulin in patients with Type 2 diabetes in Spain
Rodríguez, J
Terrés, CR
Bolinder, B
de Pablos, P
DIABETOLOGIA, 2004, 47 : A344 - A344
[7] COST-UTILITY OF INSULIN GLARGINE COMPARED TO NPH IN TYPE DMI FROM A PUBLIC PAYER PERSPECTIVE IN POLAND
McEwan, P.
Woehl, A.
Kawalec, P.
Lis, J.
Gierczynski, J.
Walczak, J.
VALUE IN HEALTH, 2008, 11 (06) : A508 - A509
[8] Insulin glargine versus NPH insulin in patients with type 1 diabetes
Ratner, R
DRUGS OF TODAY, 2003, 39 (11) : 867 - 876
[9] Evaluation of the cost-utility of insulin detemir compared to insulin glargine, both in combination with insulin aspart in type-1 diabetes in Germany and Austria
Roze, S
Wittrup-Jensen, KU
Valentine, WJ
Palmer, AJ
VALUE IN HEALTH, 2005, 8 (06) : A166 - A167
[10] A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes
Home, PD
Rosskamp, R
Forjanic-Klapproth, J
Dressler, A
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (06) : 545 - 553

← 1 2 3 4 5 →